Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 29 Feb 2012 |
| CORRECTION: Members of the Board of Directors', Executive Management's and close relations' trading in Novozymes A/S B shares | 29 Feb 2012 |
| Members of the Board of Directors', Executive Management's and close relations' trading in Novozymes A/S B shares | 29 Feb 2012 |
| Members of the Board of Directors, Executive Managements and close relations' trading in Novozymes AS/S B shares | 28 Feb 2012 |
| members of the Board of Directors', Executive Management's and close relations trading in Novozymes A/S B shares | 27 Feb 2012 |